Exiris makes use of several platform technologies for target identification and validation. In addition, Exiris is developing its own antibody and drug conjugate technologies: Cancer stem cell platform, Drug conjugate technology and Antibody ID technology.
read moreTechnologies
Services
Exiris provides contract research services and collaborative development agreements using its innovative technology platforms: CSC Platform, Target ID, Drug-Conjugate platform, Custom human mAb production, Biomarker discovery and (…)
read moreJob opportunities
Despite no open positions are currently available, feel free to apply here: Exiris will save your CV in a database that will be consulted when in search of new experienced and highly motivated collaborators.
read more
27Mar
Interview with Paola Gallinari on “Osservatorio medico-scientifico”
Click here to read the complete interview.. Read More →
Contact us
Exiris srl
Laboratories:
Via Castel Romano 100
00128 Roma RM – Italy
Legal address:
Viale Carlo Felice 103
00185 Rome – Italy
+39 06 50576530
www.exiris.it
info@exiris.it